PharmaLogic Holdings
Montreal, QC, Canada / US operations
Program data pending ClinicalTrials.gov matching
—
Not Assessed
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
✓ Press (10)
Signal Score & Pillar Breakdown
Quality Compliance
—
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesRadiopharmaceuticals, Radioligand Therapy, Therapeutic radionuclide manufacturing, Lu-177, Clinical & Commercial GMP
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
—
Insufficient financial data. Score requires company profile or SEC filings.
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity
—
Insufficient capacity data. Score requires company profile with manufacturing site information.
Recent Press10 articles
Broad modality coverage (5 modalities)
Recent News 10 articles
PharmaLogic to Acquire Majority Stake in Agilera, Strengthening Global Expertise in Radiopharmaceutical Therapeutics - PR Newswire
PharmaLogic announces opening of radiopharmaceutical production facility in Los Angeles - PR Newswire
PharmaLogic Opens Radiopharmaceutical Production Plant in NYC - Pharmaceutical Commerce
PharmaLogic Holdings Corp. Acquires Majority Stake in Agilera Pharma AS - Pharmaceutical Executive
PharmaLogic Opens New Radiopharmaceutical Production Facility in Cincinnati - Contract Pharma
PharmaLogic announces opening of new state-of-the-art radiopharmaceutical production facility in Cincinnati - PR Newswire
PharmaLogic announces opening of radiopharmaceutical production facility in New York City - PR Newswire
Intermountain Health and PharmaLogic Partner to Develop and Expand Access to Novel Radiopharmaceuticals at New Salt Lake City Facility - PR Newswire
PharmaLogic Announces Appointment of Etienne Montagut as President and Chief Executive Officer - PR Newswire
PharmaLogic announces opening of new state-of-the-art radiopharmaceutical production facility in Salt Lake City - PR Newswire
Represent this organization? Contact us to verify or update this profile.